The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients with Psoriatic Arthritis

Dec 23, 2025

- Dec 22, 2026

1.0

Claim your AMA PRA Category 1 Credits or CNE Contact Hours

This course is available for logged in users only. Please login or register to take the course.

ASH2025 Update on Management of Anemia in Patients with Myelofibrosis

Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...